Sec Form 4 Filing - Schmidt Alex @ TORtec Group Corp - 2018-12-14

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Schmidt Alex 2. Issuer Name and Ticker or Trading Symbol TORtec Group Corp [ TRTK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Vice President (Last) (First) (Middle) FLAT 108, LEONIDOU 10 3. Date of Earliest Transaction (MM/DD/YY) 12/14/2018 (Street) LIVADIA (LARNACA), G47060 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 12/14/2018 J( 1 ) 13,500,000 A $ 0 13,500,000 D Common Stock 12/14/2018 J( 1 ) 6,885,000 D $ 0 6,750,000 I TOR Biologos GmbH ( 1 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Schmidt Alex FLAT 108, LEONIDOU 10 LIVADIA (LARNACA), G47060 X X Vice President Signatures /s/ Alex Schmidt 12/14/2018 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Effective December 14, 2018, MTM Center GmbH transferred all of its 13,500,000 shares to Alex Schmidt for no consideration. Prior to this transfer, Mr. Schmidt owned 51% of MTM Center GmbH which gave him indirect beneficial ownership of 6,885,000 of the shares held by MTM Center GmbH. Mr. Schmidt now directly owns all 13,500,000 shares that were previously owned by MTM Center GmbH. Maksim Goncharenko, who owned 49% of MTM Center GmbH, agreed to the transfer as a settlement of a dispute. In addition, Mr. Schmidt continues to indirectly beneficially own 6,750,000 shares of the 13,500,000 shares held by TOR Biologos GmbH.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.